The role of reduced growth rate in the development of drug resistance of HOB1 lymphoma cells to vincristine.

An MDR cell line resistant to 1.0 microM vincristine (designated HOB1/VCR1.0) was established. The growth rate of HOB1/VCR1.0 cells was slow. The cells did not go into active proliferation although the drug treatment was released for two months (revertant cells). The HOB1/VCR1.0 cell line and its revertant were resistant to a high dose of vincristine (up to 20 microM). These two cell lines showed a decrease in expression of the hyperphosphorylated form of the retinoblastoma protein, of which the hypophosphorylated form has been considered to be a tumor suppressor. Similar phenomena were observed in the parental cells surviving brief treatment with a lethal dose of vincristine (0.05 microM). The current study gives the impression that self-inhibited growth rate may participate in the initial drug resistance before the expression of P-glycoprotein when tumor cells are suddenly exposed to chemotherapeutic agents.

[1]  E. Harlow,et al.  The retinoblastoma protein is phosphorylated during specific phases of the cell cycle , 1989, Cell.

[2]  I. Pastan,et al.  Expression of a multidrug-resistance gene in human tumors and tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[3]  I. Pastan,et al.  Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. , 1987, The Journal of biological chemistry.

[4]  M. Kao,et al.  Multidrug resistant HOB1 lymphoma cells express P-glycoprotein that does not play the major role in the development of drug resistance to adriamycin. , 1992, Biochemical and biophysical research communications.

[5]  J. Endicott,et al.  The biochemistry of P-glycoprotein-mediated multidrug resistance. , 1989, Annual review of biochemistry.

[6]  C. Marshall.  Tumor suppressor genes , 1991, Cell.

[7]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[8]  V. Ling,et al.  Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  P. Houghton,et al.  In situ selection of a human rhabdomyosarcoma resistant to vincristine with altered beta-tubulins. , 1985, Cancer research.

[10]  J. L. Biedler,et al.  Increased synthesis of a low molecular weight protein in vincristine-resistant cells. , 1981, Biochemical and biophysical research communications.

[11]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[12]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[13]  F. Sirotnak,et al.  Altered molecular properties of tubulin in a multidrug‐resistant variant of Chinese hamster cells selected for resistance to vinca alkaloids , 1988, Journal of cellular physiology.

[14]  I. Pastan,et al.  Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. , 1986, The Journal of biological chemistry.